Datum Källa Rubrik Typ Alternativ
2021-02-25 Sedana Medical Sedana Medical AB (publ), Bokslutskommuniké 2020 Rapporter Ladda ner | Visa Stäng
2021-02-25 Sedana Medical Sedana Medical AB (publ), Fourth Quarter and Year-end Report Rapporter Ladda ner | Visa Stäng
2021-02-24 Sedana Medical Sedana Medical's CEO Christer Ahlberg is leaving the company Pressreleaser Ladda ner | Visa Stäng
2021-02-24 Sedana Medical Sedana Medicals vd Christer Ahlberg lämnar bolaget Pressreleaser Ladda ner | Visa Stäng
2021-02-22 Sedana Medical Sedana Medical: First patient included in pediatric study IsoCOMFORT Pressreleaser Ladda ner | Visa Stäng
2021-02-22 Sedana Medical Sedana Medical: Första patienten inkluderad i pediatrisk IsoCOMFORT-studie Pressreleaser Ladda ner | Visa Stäng
2021-02-19 Sedana Medical Sedana Medical lämnar in ansökan om marknadsgodkännande i Storbritannien Pressreleaser Ladda ner | Visa Stäng
2021-02-19 Sedana Medical Sedana Medical submits application for market approval in UK Pressreleaser Ladda ner | Visa Stäng
2021-01-20 Sedana Medical Sedana Medical submits application for marketing approval in Switzerland Pressreleaser Ladda ner | Visa Stäng
2021-01-20 Sedana Medical Sedana Medical lämnar in ansökan om marknadsgodkännande i Schweiz Pressreleaser Ladda ner | Visa Stäng
2020-12-17 Sedana Medical Sedana Medical presents research grant recipients 2020 Pressreleaser Ladda ner | Visa Stäng
Pressreleaser | 17 Dec 2020 | Sedana Medical

Sedana Medical presents research grant recipients 2020

One of Sedana Medical’s missions is to improve patient outcomes through medical innovation. Sedana Medical Research Grant (SMRG) was established in 2019 to stimulate and support international academic research and increase awareness and knowledge in sedation of critically ill, mechanically ventilated Intensive Care Unit (ICU) patients. Sedana Medical grants one to three individual academic researchers between €10 000 and €30 000 per year, for up to two years, through Sedana Medical Research Grant.

”We are happy for the great interest in moving research forward and improving patient care in this important medical field and wish all research groups success in their research,” said Peter Sackey, CMO of Sedana Medical.

Many well-written and interesting applications were submitted. After independent scientific review by two external reviewers and the Clinical Development Committee at Sedana Medical, three research projects were prioritized for funding in 2020. Each of these will contribute to forward the science and expand knowledge within ICU sedation in its own way:

Dr Christopher Lai, MD, Professor Xavier Monnet, MD, and Tài Pham, MD, PhD, Medical Intensive Care Unit, Hôpital Bicêtre, University Paris-Saclay, Le Kremlin-Bicêtre, France

Effects of sevoflurane on extravascular lung water and pulmonary vascular permeability in patients with acute respiratory distress syndrome

Patients with ARDS and treated with sevoflurane have reduced lung inflammatory response and improved oxygenation. Preclinical studies of inhaled sedation in experimental ARDS have shown reduction in lung edema but this has not been studied in humans. In this study it is hypothesized that the mechanism behind sevoflurane-mediated improved oxygenation in ARDS is reduced lung edema. This research project will evaluate the effects of inhaled sedation via the AnaConDa, compared with propofol, on extravascular lung water index (EVLWi) and the pulmonary vascular permeability index (PVPI) in ARDS patients. The aim of the study is to increase the understanding of the lung-protective effects of inhaled sedation in ARDS.

Armin Flinspach, MD and Elisabeth Adam, MD, Department of Anesthesiology, Intensive Care Medicine and Pain Therapy University Hospital, Frankfurt, Germany and Goethe University, Frankfurt, Germany

Volatile short-term sedation in patients undergoing cardiac valve surgery: a prospective randomized controlled trial

Following cardiac surgery, sedatives are routinely administered in the intensive care unit (ICU) to facilitate mechanical ventilation. Due to the advancing age of complex cardiac surgery patients, with an increasing prevalence of liver and kidney dysfunction, the metabolism of intravenous sedatives is in part severely impaired and may lead to oversedation, prolonged mechanical ventilation, delirium and drug-induced hypotension. There is increasing data that volatile sedation promotes faster patient awakening and shorter extubation times in the surgical critical care setting. Specifically, (multiple) valve surgery requiring prolonged intervention and time on cardiopulmonary bypass are different from CABG surgery. These variables may lead to different outcomes than in patients following CABG surgery. The aim of the study is to investigate whether patients undergoing cardiac valve surgery will benefit from the postoperative administration of volatile anesthetics.

Francois Labaste, MD, Professor Vincent Miniville, MD, Professor Bertrand Marcheix, MD, Service d’Anesthésie et Réanimation, Chirurgie cardiaque, Centre Hospitalier Universitaire de Toulouse, France

AnaConDa Device in cardiac surgery: an easy solution to achieve total inhalation anesthesia with sevoflurane

Volatile (inhaled) anesthetic agents have cardioprotective effects. Administration before a prolonged cardiac ischaemic episode is known as anaesthetic preconditioning. Several clinical studies indicate that volatile anesthetics given during cardiac surgery confer myocardial protection and reduce the risk of perioperative myocardial infarction, myocardial dysfunction, and death. Other randomized trials did not confirm a benefit of volatile anesthetics on long-term mortality but in these, inhaled anaesthetics were not given during cardio-pulmonary bypass (CPB) due to a lack of vaporizing methods during CPB. The research team have found and successfully implemented a method to administer inhaled anaesthetics via the AnaConDa during CPB, enabling total inhaled anesthesia throughout the entire surgical procedure. The main aim of the trial, comparing total inhaled anesthesia and postoperative sedation with intravenous anesthesia and sedation is to describe the feasibility and the safety of use of the AnaConDa during cardiac surgery with CPB.

 

The next SMRG call for proposals is planned for mid-2021. For more information on the grant and application procedure please visit: www.sedanamedical.com

For additional information, please contact:

Peter Sackey, CMO of Sedana Medical
Mobile: +46 70 771 03 64
E-mail: peter.sackey@sedanamedical.com

 

Sedana Medical is listed on Nasdaq First North Growth Market in Stockholm.
The company’s Certified Adviser is Erik Penser Bank, +46 8 463 83 00, certifiedadviser@penser.se.

The information was released for public disclosure, through the agency of the contact person above, on December 17, 2020 at 08:00 am (CET).

About Sedana Medical

Sedana Medical AB (publ) develops and sells the medical device AnaConDa for the administration of volatile anaesthetics. Through a combination of AnaConDa and the drug candidate Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated intensive care patients. The company has applied for marketing approval in Europe for Sedaconda and expects an approval in the second half of 2021.

Today, mechanically ventilated intensive care patients are sedated intravenously which leads to several challenges for both patients and care givers. Challenges that are solved by inhaled sedation. Globally, seven to eight million patients are estimated to be sedated in intensive care due to mechanical ventilation, evenly distributed between the US, Europe, and Asia. These patients are on average sedated three to four days. Sedana Medical estimates the total market potential to SEK 20-30 billion. Three years after marketing approval in Europe, Sedana Medical expects sales of SEK 500 million in Europe and an EBITDA margin of about 40 percent. The company has initiated processes to obtain marketing approval in the US in 2024 and in markets outside the EU.

Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, the Nordics and Spain as well as external distributors in other parts of Europe, Australia, Canada, China, India, Israel, Japan, Mexico and South Korea. The company was founded in 2005 and is headquartered in Stockholm, Sweden, with medical device development in Ireland.

2020-12-08 Sedana Medical Sedana Medicals Sedaconda-studie presenteras på ESICM Pressreleaser Ladda ner | Visa Stäng
2020-12-08 Sedana Medical Sedana Medical's Sedaconda study presented at ESICM Pressreleaser Ladda ner | Visa Stäng
2020-11-27 Sedana Medical Sedana Medical submits market approval application for the drug Sedaconda Pressreleaser Ladda ner | Visa Stäng
2020-11-27 Sedana Medical Sedana Medical lämnar in ansökan om marknadsgodkännande för läkemedlet Sedaconda Pressreleaser Ladda ner | Visa Stäng
2020-11-11 Sedana Medical Sedana Medical receives additional patent for AnaConDa Pressreleaser Ladda ner | Visa Stäng
2020-11-11 Sedana Medical Sedana Medical erhåller ytterligare patent för AnaConDa Pressreleaser Ladda ner | Visa Stäng
2020-11-05 Sedana Medical Sedana Medical AB (publ), kvartalsrapport 3, 2020 Rapporter Ladda ner | Visa Stäng
2020-11-05 Sedana Medical Sedana Medical AB (publ), interim report Q3, 2020 Rapporter Ladda ner | Visa Stäng
2020-10-23 Sedana Medical Sedana Medicals valberedning utsedd Pressreleaser Ladda ner | Visa Stäng
2020-10-23 Sedana Medical Sedana Medical's nomination committee appointed Pressreleaser Ladda ner | Visa Stäng
2020-10-07 Sedana Medical AnaConDa from Sedana Medical reviewed by NICE in UK Pressreleaser Ladda ner | Visa Stäng
2020-10-05 Sedana Medical Sedana Medical utser ny CFO Pressreleaser Ladda ner | Visa Stäng
2020-10-05 Sedana Medical Sedana Medical appoints new CFO Pressreleaser Ladda ner | Visa Stäng
2020-09-30 Sedana Medical Sedana Medical's CEO divests shares - remains a committed and long-term shareholder Pressreleaser Ladda ner | Visa Stäng
2020-09-30 Sedana Medical Sedana Medicals vd avyttrar aktier - kvarstår som dedikerad långsiktig ägare Pressreleaser Ladda ner | Visa Stäng
2020-08-25 Sedana Medical Sedana Medical AB (publ), kvartalsrapport 2, 2020 Rapporter Ladda ner | Visa Stäng
2020-08-25 Sedana Medical Sedana Medical AB (publ), interim report Q2, 2020 Rapporter Ladda ner | Visa Stäng
2020-08-19 Sedana Medical Sedana Medical signs distribution agreement in Australia and New Zeeland Pressreleaser Ladda ner | Visa Stäng
2020-08-19 Sedana Medical Sedana Medical tecknar distributionsavtal i Australien och Nya Zeeland Pressreleaser Ladda ner | Visa Stäng
2020-07-10 Sedana Medical Sedana Medical meddelar positivt top line-resultat i registreringsgrundande IsoConDa-studie Pressreleaser Ladda ner | Visa Stäng
2020-07-10 Sedana Medical Sedana Medical announces positive top line result in pivotal IsoConDa study Pressreleaser Ladda ner | Visa Stäng
2020-07-01 Sedana Medical Sedana Medical får godkännande i Saudiarabien och sluter distributionsavtal i Mellanöstern Pressreleaser Ladda ner | Visa Stäng
2020-07-01 Sedana Medical Sedana Medical receives market approval in Saudi Arabia and signs distribution agreements for the Middle East Pressreleaser Ladda ner | Visa Stäng
2020-06-25 Sedana Medical Sedana Medical expanderar i Östeuropa - sluter distributionsavtal Pressreleaser Ladda ner | Visa Stäng
2020-06-25 Sedana Medical Sedana Medical expands in Eastern Europe - signs distribution agreements Pressreleaser Ladda ner | Visa Stäng
2020-05-20 Sedana Medical Sedana Medical: Utnyttjande av teckningsoptioner i incitamentsprogram 2017/21 Pressreleaser Ladda ner | Visa Stäng
2020-05-19 Sedana Medical Bulletin from the Annual General Meeting in Sedana Medical Pressreleaser Ladda ner | Visa Stäng
2020-05-19 Sedana Medical Kommuniké från årsstämma i Sedana Medical Pressreleaser Ladda ner | Visa Stäng
2020-05-15 Sedana Medical Sedana Medical: Första patienten inkluderad i SESAR-studien om lungprotektion Pressreleaser Ladda ner | Visa Stäng
2020-05-12 Sedana Medical Sedana Medical stöder multinationell inhalationssederingsstudie i covid-19 ARDS Pressreleaser Ladda ner | Visa Stäng
2020-05-07 Sedana Medical Sedana Medical AB (publ), interim report Q1, 2020 Rapporter Ladda ner | Visa Stäng
2020-05-07 Sedana Medical Sedana Medical AB (publ), kvartalsrapport 1, 2020 Rapporter Ladda ner | Visa Stäng
2020-04-22 Sedana Medical Sedana Medicals årsredovisning för 2019 offentliggjord Rapporter Ladda ner | Visa Stäng
2020-04-22 Sedana Medical Sedana Medical publishes its Annual Report for 2019 Pressreleaser Ladda ner | Visa Stäng
2020-04-16 Sedana Medical Notice of Annual General Meeting in Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2020-04-16 Sedana Medical Kallelse till årsstämma i Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2020-04-09 Sedana Medical The nomination committee's resolution proposals for election of board members etc. at the annual general meeting in Sedana Medical Pressreleaser Ladda ner | Visa Stäng
2020-04-09 Sedana Medical Valberedningens förslag till val av styrelseledamöter m.m. inför årsstämman i Sedana Medical Pressreleaser Ladda ner | Visa Stäng
2020-04-06 Sedana Medical Sedana Medical's sales increase around 90 percent Pressreleaser Ladda ner | Visa Stäng
2020-04-06 Sedana Medical Sedana Medical ökar omsättningen cirka 90 procent Pressreleaser Ladda ner | Visa Stäng
2020-03-30 Sedana Medical Sedana Medical ser ökad efterfrågan och håller tidplanen Pressreleaser Ladda ner | Visa Stäng
2020-03-30 Sedana Medical Sedana Medical sees increased demand and keeps time schedule Pressreleaser Ladda ner | Visa Stäng
2020-03-20 Sedana Medical Sedana Medical: AnaConDa e-learning released to meet increased inquiries related to COVID-19 Pressreleaser Ladda ner | Visa Stäng
2020-03-05 Sedana Medical Sedana Medical AB (publ), Year-end report, 2019 Pressreleaser Ladda ner | Visa Stäng
2020-03-05 Sedana Medical Sedana Medical AB (publ), bokslutskommuniké, 2019 Pressreleaser Ladda ner | Visa Stäng
2020-02-27 Sedana Medical Sedana Medical donerar AnaConDa till sjukhus i Wuhan, Kina Pressreleaser Ladda ner | Visa Stäng
2020-02-27 Sedana Medical Sedana Medical donates AnaConDa to hospitals in Wuhan, China Pressreleaser Ladda ner | Visa Stäng
2020-02-05 Sedana Medical Sedana Medical etablerar försäljningsorganisation i Benelux Pressreleaser Ladda ner | Visa Stäng
2020-02-05 Sedana Medical Sedana Medical establishes sales organization in Benelux Pressreleaser Ladda ner | Visa Stäng
2020-01-28 Sedana Medical Sedana Medical erhåller godkännande för AnaConDa i Mexico Pressreleaser Ladda ner | Visa Stäng
2020-01-28 Sedana Medical Sedana Medical receives approval for AnaConDa in Mexico Pressreleaser Ladda ner | Visa Stäng
2020-01-20 Sedana Medical Sedana Medical's CEO divests shares - remains committed and long-term shareholder Pressreleaser Ladda ner | Visa Stäng
2020-01-20 Sedana Medical Sedana Medicals VD avyttrar aktier - kvarstår som dedikerad långsiktig ägare Pressreleaser Ladda ner | Visa Stäng
2020-01-13 Sedana Medical Sista patienten inkluderad i Sedana Medicals registreringsgrundande IsoConDa-studie Pressreleaser Ladda ner | Visa Stäng
2019-12-04 Sedana Medical Sedana Medical stöder sederingsstudie med isofluran för minskning av delirium Pressreleaser Ladda ner | Visa Stäng
2019-12-04 Sedana Medical Sedana Medical supports isoflurane sedation study for reduction of delirium Pressreleaser Ladda ner | Visa Stäng
2019-11-13 Sedana Medical Sedana Medical AB (publ), Interim report Q3, 2019 Rapporter Ladda ner | Visa Stäng
2019-11-13 Sedana Medical Sedana Medical AB (publ), kvartalsrapport 3, 2019 Rapporter Ladda ner | Visa Stäng
2019-11-12 Sedana Medical Sedana Medicals styrelseledamot Michael Ryan avgår Pressreleaser Ladda ner | Visa Stäng
2019-11-12 Sedana Medical Sedana Medical's board member Michael Ryan resigns Pressreleaser Ladda ner | Visa Stäng
2019-11-08 Sedana Medical Sedana Medical justerar och förtydligar sina långsiktiga finansiella mål Pressreleaser Ladda ner | Visa Stäng
2019-11-08 Sedana Medical Sedana Medical adjusts and clarifies its long-term financial targets Pressreleaser Ladda ner | Visa Stäng
2019-10-17 Sedana Medical Sedana Medicals valberedning utsedd Pressreleaser Ladda ner | Visa Stäng
2019-10-16 Sedana Medical Sedana Medical delfinansierar AnaConDa-studie om lungprotektion Pressreleaser Ladda ner | Visa Stäng
2019-10-09 Sedana Medical Sedana Medical AB (publ) genomför en riktad nyemission om 2 896 000 aktier och tillförs 375 miljoner SEK Pressreleaser Ladda ner | Visa Stäng
2019-10-09 Sedana Medical Sedana Medical AB (publ) has completed a directed new share issue of 2,896,000 shares, raising proceeds of SEK 375 million Pressreleaser Ladda ner | Visa Stäng
2019-10-09 Sedana Medical Sedana Medical AB (publ) prepares for listing on the Nasdaq Stockholm main market Pressreleaser Ladda ner | Visa Stäng
2019-10-09 Sedana Medical Sedana Medical AB (publ) intends to undertake a directed new share issue Pressreleaser Ladda ner | Visa Stäng
2019-10-09 Sedana Medical Sedana Medical AB (publ) avser genomföra en riktad nyemission av aktier Pressreleaser Ladda ner | Visa Stäng
2019-10-09 Sedana Medical Sedana Medical AB (publ) förbereder notering på Nasdaq Stockholms huvudlista Pressreleaser Ladda ner | Visa Stäng
2019-09-30 Sedana Medical Sedana Medicals AnaConDa godkänd för användning på barn Pressreleaser Ladda ner | Visa Stäng
2019-08-22 Sedana Medical Sedana Medical AB (publ), Interim report Q2, 2019 Rapporter Ladda ner | Visa Stäng
2019-08-22 Sedana Medical Sedana Medical AB (publ), kvartalsrapport 2, 2019 Rapporter Ladda ner | Visa Stäng
2019-08-15 Sedana Medical Sedana Medical enters India - signs Indian distributor Pressreleaser Ladda ner | Visa Stäng
2019-08-15 Sedana Medical Sedana Medical går in i Indien - sluter avtal med indisk distributör Pressreleaser Ladda ner | Visa Stäng
2019-05-28 Sedana Medical Kommuniké från årsstämma i Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2019-04-25 Sedana Medical Sedana Medicals årsredovisning för 2018 offentliggjord Pressreleaser Ladda ner | Visa Stäng
2019-03-12 Sedana Medical Sedana Medical bokslutskommuniké, januari - december 2018. - Stark tillväxt och positiv utveckling av registreringsarbetet Rapporter Ladda ner | Visa Stäng
2019-03-12 Sedana Medical Sedana Medical Year-end Report, January - December 2018. - Strong growth and positive registration work development Rapporter Ladda ner | Visa Stäng
2019-03-08 Sedana Medical Sedana Medical: Positive interim analysis in pivotal IsoConDa phase III study Pressreleaser Ladda ner | Visa Stäng
2019-03-08 Sedana Medical Sedana Medical: Positiv interimanalys av IsoConDa fas III registreringsstudie Pressreleaser Ladda ner | Visa Stäng
2019-03-07 Sedana Medical Tidigarelagt datum för release av Sedana Medicals bokslutskommuniké 2018 Pressreleaser Ladda ner | Visa Stäng
2019-02-12 Sedana Medical Sedana Medical får klartecken för pediatrisk studie  - Milstolpe på vägen mot marknadsexklusivitet Pressreleaser Ladda ner | Visa Stäng
2019-02-12 Sedana Medical Sedana Medical receives go-ahead for pediatric study  - Milestone on the road to market exclusivity Pressreleaser Ladda ner | Visa Stäng
2018-12-03 Sedana Medical Rättelse av tidigare utskickad pressrelease Sedana Medical AB (publ), Sedana Medicals valberedning utsedd Pressreleaser Ladda ner | Visa Stäng
2018-12-03 Sedana Medical Amendment of previously announced press release Sedana Medical AB (publ), Sedana Medical's nomination committee appointed Pressreleaser Ladda ner | Visa Stäng
2018-12-03 Sedana Medical Sedana Medical's nomination committee appointed Pressreleaser Ladda ner | Visa Stäng
2018-12-03 Sedana Medical Sedana Medicals valberedning utsedd Pressreleaser Ladda ner | Visa Stäng
2018-11-22 Sedana Medical Sedana Medical AB (publ), Interim report Q3, 2018 Rapporter Ladda ner | Visa Stäng
2018-11-22 Sedana Medical Sedana Medical AB (publ), Kvartalsrapport 3, 2018 Rapporter Ladda ner | Visa Stäng
2018-11-14 Sedana Medical Sedana Medical visar betydande hälsoekonomiska fördelar med AnaConDa Pressreleaser Ladda ner | Visa Stäng
2018-11-02 Sedana Medical Sedana Medical receives approval for AnaConDa in Japan Pressreleaser Ladda ner | Visa Stäng
2018-11-02 Sedana Medical Sedana Medical erhåller godkännande för AnaConDa i Japan Pressreleaser Ladda ner | Visa Stäng
2018-09-27 Sedana Medical Sedana Medical AB (publ) - Första direktförsäljningen av AnaConDa i Storbritannien. Pressreleaser Ladda ner | Visa Stäng
2018-09-20 Sedana Medical Genomförd försäljning av aktier i Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2018-09-20 Sedana Medical Completed sale of shares in Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2018-08-30 Sedana Medical Rättelse av tidigare utskickat pressmeddelande Sedana Medical AB (publ), Kvartalsrapport 2, 2018 Rapporter Ladda ner | Visa Stäng
2018-08-30 Sedana Medical Correction of previously announced press release Sedana Medical AB (publ), Interim report Q2, 2018 Rapporter Ladda ner | Visa Stäng
2018-08-30 Sedana Medical Sedana Medical AB (publ), Interim report Q2, 2018 Rapporter Ladda ner | Visa Stäng
2018-08-30 Sedana Medical Sedana Medical AB (publ), Kvartalsrapport 2, 2018 Rapporter Ladda ner | Visa Stäng
2018-08-22 Sedana Medical Sedana Medical bjuder in till webbsänd telefonpresentation av bolagets delårsrapport för det andra kvartalet 2018 Pressreleaser Ladda ner | Visa Stäng
2018-07-26 Sedana Medical Sedana Medical AB (publ) återupptar sin fas 3-studie IsoConDa med full patientrekryteringstakt. Pressreleaser Ladda ner | Visa Stäng
2018-07-26 Sedana Medical Sedana Medical AB (publ) resumes pivotal phase 3-study IsoConDa with full patient recruitment rate. Pressreleaser Ladda ner | Visa Stäng
2018-06-18 Sedana Medical Sedana Medical AB (publ) rekryterar Global Marketing Director. Pressreleaser Ladda ner | Visa Stäng
2018-06-18 Sedana Medical Sedana Medical AB (publ) recruits Global Marketing Director Pressreleaser Ladda ner | Visa Stäng
2018-06-05 Sedana Medical Sedana Medical AB (publ) has completed a directed new share issue of approximately SEK 112 million directed to institutional investors Pressreleaser Ladda ner | Visa Stäng
2018-06-05 Sedana Medical Sedana Medical AB (publ) har genomfört en riktad nyemission om cirka 112 miljoner kronor riktad till institutionella investerare Pressreleaser Ladda ner | Visa Stäng
2018-06-04 Sedana Medical Sedana Medical AB (publ) avser genomföra en riktad nyemission av aktier Pressreleaser Ladda ner | Visa Stäng
2018-06-04 Sedana Medical Sedana Medical AB (publ) intends to undertake a directed new share issue Pressreleaser Ladda ner | Visa Stäng
2018-05-22 Sedana Medical Kommuniké från årsstämma i Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2018-05-22 Sedana Medical Bulletin from annual general meeting in Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2018-05-22 Sedana Medical Sedana Medical AB (publ), Delårsrapport Kvartal 1, 2018. Rekordstark försäljning och ökad marknadsnärvaro Rapporter Ladda ner | Visa Stäng
2018-04-25 Sedana Medical Sedana Medicals årsredovisning för 2017 offentliggjord Rapporter Ladda ner | Visa Stäng
2018-04-12 Sedana Medical Sedana Medical AB (publ) redovisar rekordstor försäljningsökning under första kvartalet 2018. Pressreleaser Ladda ner | Visa Stäng
2018-04-11 Sedana Medical Sedana Medical AB (publ) bjuder in till telefonkonferensmöte baserat på uppdaterad tidsplan för IsoConDa studien. Pressreleaser Ladda ner | Visa Stäng
2018-04-10 Sedana Medical Sedana Medical AB (publ) uppdaterar tidsplanen för IsoConDa studien. Pressreleaser Ladda ner | Visa Stäng
2018-04-09 Sedana Medical Kallelse till årsstämma i Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2018-03-27 Sedana Medical Sedana Medical AB (publ), Bokslutskommuniké 2017: Stark försäljningsutveckling och ökat intresse för AnaConDa och inhalationssedering. Rapporter Ladda ner | Visa Stäng
2018-03-20 Sedana Medical Sedana Medical AB:s (publ) meddelar valberednings förslag till ny styrelse inför årsstämman 2018 Pressreleaser Ladda ner | Visa Stäng
2018-03-01 Sedana Medical Sedana Medical AB (publ) startar egen försäljningsverksamhet i Norge och Danmark. Pressreleaser Ladda ner | Visa Stäng
2017-12-18 Sedana Medical Sedana Medical AB (publ) byter Certified Adviser från Pareto Securities AB till Erik Penser Bank. Pressreleaser Ladda ner | Visa Stäng
2017-11-30 Sedana Medical Sedana Medical AB (publ), Delårsrapport 3, juli-september 2017: Fortsatt stark försäljningsutveckling och registreringsstudien för Europa enligt plan Rapporter Ladda ner | Visa Stäng
2017-11-23 Sedana Medical Sedana Medical AB (publ) ansöker om registrering av AnaConDa i Japan Pressreleaser Ladda ner | Visa Stäng
2017-10-04 Sedana Medical Sedana Medical AB (publ) rekryterar Peter Sackey som Medicinsk Chef, Chief Medical Officer (CMO). Pressreleaser Ladda ner | Visa Stäng
2017-08-31 Sedana Medical Sedana Medical AB (publ), Delårsrapport kvartal 2, januari-juni 2017 Rapporter Ladda ner | Visa Stäng
2017-08-31 Sedana Medical Sedana Medical AB (publ), Interim Report, Q2, January-June 2017 Rapporter Ladda ner | Visa Stäng
2017-07-07 Sedana Medical Exercise of the overallotment option Pressreleaser Ladda ner | Visa Stäng
2017-07-07 Sedana Medical Utnyttjande av övertilldelningsoptionen Pressreleaser Ladda ner | Visa Stäng
2017-07-06 Sedana Medical Sedana Medical har uppnått en ny viktig milstolpe - Den första behandlade patienten med AnaConDa i Asien. Pressreleaser Ladda ner | Visa Stäng
2017-07-06 Sedana Medical Sedana Medical reaches an important milestone - The first patient in Asia is treated with AnaConDa. Pressreleaser Ladda ner | Visa Stäng
2017-06-29 Sedana Medical Sedana Medical AB (publ) in final deal with Teleflex Medical Incorporation Pressreleaser Ladda ner | Visa Stäng
2017-06-29 Sedana Medical Sedana Medical AB (publ) i slutlig uppgörelse med Teleflex Medical Incorporation Pressreleaser Ladda ner | Visa Stäng

Kommande händelser

22 May 2018 | Årsstämma 2017
22 May 2018 | Kvartalsrapport 2018-Q1
23 May 2018 | Årligutdelning
30 Aug 2018 | Kvartalsrapport 2018-Q2
22 Nov 2018 | Kvartalsrapport 2018-Q3
21 Mar 2019 | Bokslutskommuniké 2018
25 Apr 2019 | Kvartalsrapport 2019-Q1
8 May 2019 | Kvartalsrapport 2019-Q1
28 May 2019 | Årsstämma 2018
29 May 2019 | Årligutdelning
22 Aug 2019 | Kvartalsrapport 2019-Q2
5 Mar 2020 | Bokslutskommuniké 2019
7 May 2020 | Kvartalsrapport 2020-Q1
19 May 2020 | Årsstämma 2019
20 May 2020 | Årligutdelning
25 Aug 2020 | Kvartalsrapport 2020-Q2
5 Nov 2020 | Kvartalsrapport 2020-Q3
25 Feb 2021 | Bokslutskommuniké 2020
6 May 2021 | Kvartalsrapport 2021-Q1
10 May 2021 | Årsstämma 2020
11 May 2021 | Årligutdelning
12 Aug 2021 | Kvartalsrapport 2021-Q2
4 Nov 2021 | Kvartalsrapport 2021-Q3

ca.penser.se använder cookies för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder cookies. Vad är cookies?

Jag godkänner